General
Preferred name
luminespib
Synonyms
AUY922 ()
VER-52296 ()
NVP-AUY922 ()
AUY-922 ()
AUY-922, VER-52296 ()
Luminespib (NVP-AUY922) ()
LUMINESPIB MESYLATE ()
NVP-AUY-922 ()
NVP-AUY922-NX ()
Luminespib ()
1051919-26-6 ()
Luminespib mesylate hydrate ()
NVP-AUY922-AGB ()
P&D ID
PD011154
CAS
747412-49-3
Tags
available
probe
drug candidate
Drug indication
Multiple myeloma
colorectal adenocarcinoma
Solid tumour/cancer
Drug Status
investigational
Max Phase
2.0
Probe info
Probe type
experimental probe
Probe sources
Probe targets
[[ compound.targets[t].gene_name ]]
Probe control
Probe control not defined
Orthogonal probes
25
No orthogonal probes found
Similar probes
2
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
COMMENT
AUY922 targets members of the heat shock protein 90 (Hsp90) family. This molecule binds to the N-terminal nucleotide-binding sites of Hsp90s. It is worth noting that there are other possible binding sites and mechanisms for inhibiting this target (e.g. targeting the C-terminal dimerization domain) and the pharmacology associated with these mechanisms may not be equivalent. Jul 3 2020 - 2:41pm
DESCRIPTION
Luminespib (NVP-AUY922) is an intravenous HSP90 inhibitor with the potential to target a range of cancers. Discovered during a research collaboration with Novartis, Vernalis is now looking to partner the programme. We have drawn the structure as depicted in its INN record. Other chemistry resources show alternative tautomers. For example, PubChem CID 10096043 matches on CAS registry number, but is a structural tautomer.
(GtoPdb)
DESCRIPTION
Luminespib (VER-52296) is a potent HSP90 inhibitor with IC50s of 7.8 and 21 nM for HSP90¦Á and HSP90¦Â, respectively[1].
PRICE
70
DESCRIPTION
Luminespib (VER-52296) is an HSP90 inhibitor that inhibits HSP90?? and HSP90?? (IC50=7.8/21 nM). Luminespib has antitumor activity and is used in studies of head and neck tumors, among others.
MOA
Inhibitor
(Chemical Probes.org)
DESCRIPTION
Luminespib (VER-52296) is an HSP90 inhibitor that inhibits HSP90α and HSP90β (IC50=7.8/21 nM). Luminespib has antitumor activity and is used in studies of head and neck tumors, among others.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
669
Organisms
3
Compound Sets
16
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Drugs
Chemical Probes.org
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugMAP
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
High-quality chemical probes
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
ZINC Tool Compounds
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
29
Molecular Weight
465.23
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
3
Rotatable Bonds
7
Ring Count
4
Aromatic Ring Count
3
cLogP
4.13
TPSA
108.06
Fraction CSP3
0.38
Chiral centers
0.0
Largest ring
6.0
QED
0.48
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
MOA
HSP
Heat Shock Protein 90 (hsp90) Inhibitors
HSP inhibitor
Target
HSP90¦Á
HSP90¦Â
HSP90AA1, HSP90AB1
HSP90 inhibitor
HSP90
Apoptosis related,Autophagy,HSP (HSP90),IGF-1R
HSP90α
HSP90β
Member status
virtual
Pathway
Apoptosis
Autophagy
Cytoskeletal Signaling
Metabolism
Cell Cycle/DNA Damage
Metabolic Enzyme/Protease
Target subclass
Chaperone
Chaperone , Chaperone
Target class
Other post-translational modification
Other post-translational modification, Other post-translational modification
Orthogonal probe
Onalespib
Therapeutic Class
Anticancer Agents
Source data
